CQDM to support a $1.1 M R&D project for Immune Biosolutions’ next-generation of anti-cancer treatment

News & Events

BOSTON, JUNE 6, 2018 – CQDM is pleased to announce the funding of a new $1.1 million research project in conjunction with financial contributions from lead industrial partner, Immune Biosolutions, and co-funding from: Cancer Research Society, Mitacs, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke and TransferTech. The funds will be used by the Université de Sherbrooke’s Professors Fernand Gobeil, … Read More

CQDM welcomes two new pharma members to its biopharmaceutical research consortium

News & Events

BOSTON, June 6, 2018 – CQDM is pleased to announce that Takeda Pharmaceutical Company Limited and Roche have joined the CQDM as new members. Members leverage the consortium’s strength to identify and finance innovative biopharmaceutical research projects from across Canada, with the ultimate goal of enabling the development of better treatments for patients. « Je salue la venue de ces deux … Read More

CQDM will partner with Feldan Therapeutics to support a $1.2M project, to improve a novel intra-cellular delivery technology

News & Events

QUÉBEC city, March 29, 2018 – CQDM is pleased to announce the selection of a new Quantum Leap project jointly with Feldan Therapeutics for a total amount of $1.2M. The funds will be used for further development of a breakthrough drug delivery technology, in collaboration with Professor Frédéric Calon from Laval University. CQDM’s support for this project is made possible by … Read More

CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics

News & Events

CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics The program will leverage AbCellera’s high-throughput, single-cell screening platform to allow rapid identification of functional antibodies against complex membrane proteins. MONTREAL, January 12th, 2018– CQDM and Brain Canada are proud to announce the non-dilutive funding of $1 M to … Read More